vs
Apellis Pharmaceuticals, Inc.（APLS）与HF Foods Group Inc.（HFFG）财务数据对比。点击上方公司名可切换其他公司
HF Foods Group Inc.的季度营收约是Apellis Pharmaceuticals, Inc.的1.5倍（$308.0M vs $199.9M），HF Foods Group Inc.净利率更高（-12.1% vs -29.5%，领先17.4%），HF Foods Group Inc.同比增速更快（0.9% vs -5.9%），HF Foods Group Inc.自由现金流更多（$12.1M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 2.1%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
HF Sinclair Corporation是一家总部位于美国得克萨斯州达拉斯的美国能源企业，主要生产并销售汽油、柴油、航空燃油、可再生柴油、特种润滑油产品、特种化学品，以及特种改性沥青等多种能源与化工产品。
APLS vs HFFG — 直观对比
营收规模更大
HFFG
是对方的1.5倍
$199.9M
营收增速更快
HFFG
高出6.8%
-5.9%
净利率更高
HFFG
高出17.4%
-29.5%
自由现金流更多
HFFG
多$26.4M
$-14.3M
两年增速更快
APLS
近两年复合增速
2.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $308.0M |
| 净利润 | $-59.0M | $-37.3M |
| 毛利率 | — | 16.6% |
| 营业利润率 | -25.6% | -12.8% |
| 净利率 | -29.5% | -12.1% |
| 营收同比 | -5.9% | 0.9% |
| 净利润同比 | -62.2% | 15.0% |
| 每股收益（稀释后） | $-0.40 | $-0.70 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSHFFG
| Q4 25 | $199.9M | $308.0M | ||
| Q3 25 | $458.6M | $307.0M | ||
| Q2 25 | $178.5M | $314.9M | ||
| Q1 25 | $166.8M | $298.4M | ||
| Q4 24 | $212.5M | $305.3M | ||
| Q3 24 | $196.8M | $298.4M | ||
| Q2 24 | $199.7M | $302.3M | ||
| Q1 24 | $172.3M | $295.7M |
净利润APLSHFFG
| Q4 25 | $-59.0M | $-37.3M | ||
| Q3 25 | $215.7M | $-1.1M | ||
| Q2 25 | $-42.2M | $1.2M | ||
| Q1 25 | $-92.2M | $-1.6M | ||
| Q4 24 | $-36.4M | $-43.9M | ||
| Q3 24 | $-57.4M | $-3.9M | ||
| Q2 24 | $-37.7M | $17.0K | ||
| Q1 24 | $-66.4M | $-694.0K |
毛利率APLSHFFG
| Q4 25 | — | 16.6% | ||
| Q3 25 | — | 16.4% | ||
| Q2 25 | — | 17.5% | ||
| Q1 25 | — | 17.1% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | — | 16.8% | ||
| Q2 24 | — | 17.4% | ||
| Q1 24 | — | 17.1% |
营业利润率APLSHFFG
| Q4 25 | -25.6% | -12.8% | ||
| Q3 25 | 48.7% | 0.4% | ||
| Q2 25 | -18.6% | 1.3% | ||
| Q1 25 | -50.0% | 0.4% | ||
| Q4 24 | -12.3% | -13.8% | ||
| Q3 24 | -24.0% | 0.2% | ||
| Q2 24 | -14.7% | 0.9% | ||
| Q1 24 | -36.0% | -0.0% |
净利率APLSHFFG
| Q4 25 | -29.5% | -12.1% | ||
| Q3 25 | 47.0% | -0.4% | ||
| Q2 25 | -23.6% | 0.4% | ||
| Q1 25 | -55.3% | -0.6% | ||
| Q4 24 | -17.1% | -14.4% | ||
| Q3 24 | -29.2% | -1.3% | ||
| Q2 24 | -18.9% | 0.0% | ||
| Q1 24 | -38.5% | -0.2% |
每股收益（稀释后）APLSHFFG
| Q4 25 | $-0.40 | $-0.70 | ||
| Q3 25 | $1.67 | $-0.02 | ||
| Q2 25 | $-0.33 | $0.02 | ||
| Q1 25 | $-0.74 | $-0.03 | ||
| Q4 24 | $-0.30 | $-0.84 | ||
| Q3 24 | $-0.46 | $-0.07 | ||
| Q2 24 | $-0.30 | $0.00 | ||
| Q1 24 | $-0.54 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | — |
| 总债务越低越好 | — | $106.1M |
| 股东权益账面价值 | $370.1M | $202.1M |
| 总资产 | $1.1B | $541.5M |
| 负债/权益比越低杠杆越低 | — | 0.53× |
8季度趋势，按日历期对齐
现金及短期投资APLSHFFG
| Q4 25 | $466.2M | — | ||
| Q3 25 | $479.2M | — | ||
| Q2 25 | $370.0M | — | ||
| Q1 25 | $358.4M | — | ||
| Q4 24 | $411.3M | — | ||
| Q3 24 | $396.9M | — | ||
| Q2 24 | $360.1M | — | ||
| Q1 24 | $325.9M | — |
总债务APLSHFFG
| Q4 25 | — | $106.1M | ||
| Q3 25 | — | $107.3M | ||
| Q2 25 | — | $106.0M | ||
| Q1 25 | — | $107.4M | ||
| Q4 24 | — | $108.7M | ||
| Q3 24 | — | $110.1M | ||
| Q2 24 | — | $111.4M | ||
| Q1 24 | $93.1M | $112.8M |
股东权益APLSHFFG
| Q4 25 | $370.1M | $202.1M | ||
| Q3 25 | $401.2M | $239.2M | ||
| Q2 25 | $156.3M | $239.7M | ||
| Q1 25 | $164.2M | $238.0M | ||
| Q4 24 | $228.5M | $239.3M | ||
| Q3 24 | $237.1M | $283.1M | ||
| Q2 24 | $264.3M | $286.3M | ||
| Q1 24 | $266.7M | $286.7M |
总资产APLSHFFG
| Q4 25 | $1.1B | $541.5M | ||
| Q3 25 | $1.1B | $595.1M | ||
| Q2 25 | $821.4M | $593.5M | ||
| Q1 25 | $807.3M | $581.9M | ||
| Q4 24 | $885.1M | $550.0M | ||
| Q3 24 | $901.9M | $612.8M | ||
| Q2 24 | $904.5M | $616.9M | ||
| Q1 24 | $831.9M | $603.1M |
负债/权益比APLSHFFG
| Q4 25 | — | 0.53× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | — | 0.45× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.39× | ||
| Q1 24 | 0.35× | 0.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $21.0M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $12.1M |
| 自由现金流率自由现金流/营收 | -7.1% | 3.9% |
| 资本支出强度资本支出/营收 | 0.1% | 2.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $6.6M |
8季度趋势，按日历期对齐
经营现金流APLSHFFG
| Q4 25 | $-14.2M | $21.0M | ||
| Q3 25 | $108.5M | $-6.0M | ||
| Q2 25 | $4.4M | $3.5M | ||
| Q1 25 | $-53.4M | $6.9M | ||
| Q4 24 | $19.4M | $18.4M | ||
| Q3 24 | $34.1M | $2.3M | ||
| Q2 24 | $-8.3M | $-9.3M | ||
| Q1 24 | $-133.0M | $11.2M |
自由现金流APLSHFFG
| Q4 25 | $-14.3M | $12.1M | ||
| Q3 25 | $108.3M | $-9.3M | ||
| Q2 25 | $4.4M | $363.0K | ||
| Q1 25 | $-53.4M | $3.4M | ||
| Q4 24 | $19.3M | $15.3M | ||
| Q3 24 | — | $-820.0K | ||
| Q2 24 | $-8.4M | $-13.0M | ||
| Q1 24 | $-133.3M | $8.6M |
自由现金流率APLSHFFG
| Q4 25 | -7.1% | 3.9% | ||
| Q3 25 | 23.6% | -3.0% | ||
| Q2 25 | 2.5% | 0.1% | ||
| Q1 25 | -32.0% | 1.1% | ||
| Q4 24 | 9.1% | 5.0% | ||
| Q3 24 | — | -0.3% | ||
| Q2 24 | -4.2% | -4.3% | ||
| Q1 24 | -77.3% | 2.9% |
资本支出强度APLSHFFG
| Q4 25 | 0.1% | 2.9% | ||
| Q3 25 | 0.0% | 1.1% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | 0.0% | 1.2% | ||
| Q4 24 | 0.0% | 1.0% | ||
| Q3 24 | 0.0% | 1.0% | ||
| Q2 24 | 0.0% | 1.2% | ||
| Q1 24 | 0.2% | 0.9% |
现金转化率APLSHFFG
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | 2.89× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -546.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
HFFG
| Seafood | $110.2M | 36% |
| Meat And Poultry | $62.7M | 20% |
| Asian Specialty | $55.3M | 18% |
| Commodity Product | $35.1M | 11% |
| Fresh Produce | $29.9M | 10% |
| Packaging And Other | $14.7M | 5% |
